Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Michigan Health Center COVID-19 Survey Summary Report

Michigan Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 31 (79% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 1,332
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 38.44%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 244
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 32.09%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 56.16% 59.84%
White, Hispanic/Latino Patients 5.56% 5.74%
Black/African American, Non-Hispanic/Latino Patients 17.94% 13.52%
Black/African American, Hispanic/Latino Patients 0.38% 0.41%
Asian Patients3 1.20% 0.82%
American Indian/Alaska Native Patients3 1.05% 0.41%
Native Hawaiian/Other Pacific Islander Patients3 0.23% 0.41%
Patients with More Than One Race3 3.30% 2.05%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.41% 4.92%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.00% 2.87%
Unreported/Refused to Report Race and Ethnicity 5.78% 9.02%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 286
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 46.30%
COVID-19 Immunization Series Completed 205
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 52.63%
COVID-19 Immunization Series Additional 1,048
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 33.50%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 48.25% 43.90% 61.93%
White, Hispanic/Latino Patients 6.29% 5.85% 6.39%
Black/African American, Non-Hispanic/Latino Patients 19.93% 21.46% 13.65%
Black/African American, Hispanic/Latino Patients 1.05% 0.98% 0.57%
Asian Patients3 3.85% 0.98% 1.15%
American Indian/Alaska Native Patients3 0.00% 0.98% 1.24%
Native Hawaiian/Other Pacific Islander Patients3 1.05% 0.49% 0.57%
Patients with More Than One Race3 4.20% 4.88% 1.91%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.24% 13.17% 5.73%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.85% 2.44% 1.91%
Unreported/Refused to Report Race and Ethnicity 6.29% 4.88% 4.96%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 12.90%
1 to 24 Hours 29.03%
More Than 24 Hours 58.06%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 22.58%
Vaccine confidence 41.94%
Vaccine storage capacity 6.45%
Vaccine supply 3.23%
Other 3.23%
None 38.71%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 25.81%
Average Percent of Health Center Visits Conducted Virtually 15.65%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 35.48%
Number of Mobile Van Sites 12
Number of Pop-up Clinics 19
Number of School-Based Vaccination Sites 4
Number of Family Vaccination Clinics 47

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 3.23%
Refer patients to another organization that provides monoclonal antibody therapies 80.65%
None 16.13%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 6.45%
Patient awareness/education 3.23%
Staffing capacity 9.68%
Therapy administration/onsite logistics 6.45%
Other 0.00%
None 83.87%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 24
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 14,637

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 95.83%
Provided to General Public Who Came to the Health Center 87.50%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 45.83%
Provided at Other Community Events 41.67%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 25.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 25.00%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 29.17%
Provided to school-age children and/or their families directly or through partnerships with schools 25.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 25.00%
Other 16.67%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 17
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 7,789

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 94.12%
Provided to General Public Who Came to the Health Center 88.24%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 35.29%
Provided at Other Community Events 41.18%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 17.65%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 29.41%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 23.53%
Provided to school-age children and/or their families directly or through partnerships with schools 23.53%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 29.41%
Other 5.88%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 10
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 15.46%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 75.26%
White, Hispanic/Latino Patients 6.19%
Black/African American, Non-Hispanic/Latino Patients 6.19%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 1.03%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.06%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.06%
Unreported/Refused to Report Race and Ethnicity 7.22%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 2.06%
Patients Experiencing Homelessness 1.03%
Patients Who Are Residents of Public Housing 1.03%
Patients with Limited English Proficiency 5.15%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: